• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与癌症风险关联的新视角:从机制到临床意义

Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications.

作者信息

Shi Xiaoye, Jiang Aimin, Qiu Zhengang, Lin Anqi, Liu Zaoqu, Zhu Lingxuan, Mou Weiming, Cheng Quan, Zhang Jian, Miao Kai, Luo Peng

机构信息

Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China.

The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China.

出版信息

Front Med. 2024 Dec;18(6):945-968. doi: 10.1007/s11684-024-1094-2. Epub 2024 Nov 14.

DOI:10.1007/s11684-024-1094-2
PMID:39542988
Abstract

Existing epidemiologic and clinical studies have demonstrated that obesity is associated with the risk of a variety of cancers. In recent years, an increasing number of experimental and clinical studies have unraveled the complex relationship between obesity and cancer risk and the underlying mechanisms. Obesity-induced abnormalities in immunity and biochemical metabolism, including chronic inflammation, hormonal disorders, dysregulation of adipokines, and microbial dysbiosis, may be important contributors to cancer development and progression. These contributors play different roles in cancer development and progression at different sites. Lifestyle changes, weight loss medications, and bariatric surgery are key approaches for weight-centered, obesity-related cancer prevention. Treatment of obesity-related inflammation and hormonal or metabolic dysregulation with medications has also shown promise in preventing obesity-related cancers. In this review, we summarize the mechanisms through which obesity affects the risk of cancer at different sites and explore intervention strategies for the prevention of obesity-associated cancers, concluding with unresolved questions and future directions regarding the link between obesity and cancer. The aim is to provide valuable theoretical foundations and insights for the in-depth exploration of the complex relationship between obesity and cancer risk and its clinical applications.

摘要

现有流行病学和临床研究表明,肥胖与多种癌症风险相关。近年来,越来越多的实验和临床研究揭示了肥胖与癌症风险之间的复杂关系及其潜在机制。肥胖引起的免疫和生化代谢异常,包括慢性炎症、激素紊乱、脂肪因子失调和微生物群落失调,可能是癌症发生和发展的重要因素。这些因素在不同部位的癌症发生和发展中发挥着不同作用。生活方式改变、减肥药物和减肥手术是以体重为中心的肥胖相关癌症预防的关键方法。用药物治疗肥胖相关炎症以及激素或代谢失调在预防肥胖相关癌症方面也显示出前景。在本综述中,我们总结了肥胖影响不同部位癌症风险的机制,并探索预防肥胖相关癌症的干预策略,最后提出关于肥胖与癌症之间联系的未解决问题和未来方向。目的是为深入探索肥胖与癌症风险之间的复杂关系及其临床应用提供有价值的理论基础和见解。

相似文献

1
Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications.肥胖与癌症风险关联的新视角:从机制到临床意义
Front Med. 2024 Dec;18(6):945-968. doi: 10.1007/s11684-024-1094-2. Epub 2024 Nov 14.
2
Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.肥胖生物标志物、代谢与癌症风险:流行病学视角
Recent Results Cancer Res. 2016;208:199-217. doi: 10.1007/978-3-319-42542-9_11.
3
The Impact of Obesity on Breast Cancer.肥胖对乳腺癌的影响。
Curr Oncol Rep. 2018 Apr 11;20(6):47. doi: 10.1007/s11912-018-0688-8.
4
Bariatric surgery in the prevention of obesity-associated cancers: mechanistic implications.减重手术预防肥胖相关癌症:机制影响。
Surg Obes Relat Dis. 2023 Jul;19(7):772-780. doi: 10.1016/j.soard.2023.02.016. Epub 2023 Feb 28.
5
Gender Differences in Obesity-Related Cancers.性别与肥胖相关癌症的关系。
Curr Obes Rep. 2021 Jun;10(2):100-115. doi: 10.1007/s13679-021-00426-0. Epub 2021 Feb 1.
6
Obesity, insulin resistance, and cancer prognosis: implications for practice for providing care among cancer survivors.肥胖、胰岛素抵抗与癌症预后:对癌症幸存者护理实践的启示
J Am Diet Assoc. 2009 Aug;109(8):1346-53. doi: 10.1016/j.jada.2009.05.001.
7
Obesity, adipokines and cancer: an update.肥胖、脂肪因子与癌症:最新进展
Clin Endocrinol (Oxf). 2015 Aug;83(2):147-56. doi: 10.1111/cen.12667. Epub 2014 Dec 29.
8
Tumor Metabolic Reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression.脂肪因子对肿瘤代谢的重编程作用是肥胖相关癌症进展的关键驱动因素。
Int J Mol Sci. 2021 Feb 1;22(3):1444. doi: 10.3390/ijms22031444.
9
Recent insights on modulation of inflammasomes by adipokines: a critical event for the pathogenesis of obesity and metabolism-associated diseases.近期关于脂肪因子对炎性小体调节作用的研究进展:肥胖及代谢相关性疾病发病机制中的关键事件。
Arch Pharm Res. 2020 Oct;43(10):997-1016. doi: 10.1007/s12272-020-01274-7. Epub 2020 Oct 19.
10
Adipose tissue, obesity and adipokines: role in cancer promotion.脂肪组织、肥胖与脂肪因子:在癌症促进中的作用
Horm Mol Biol Clin Investig. 2015 Jan;21(1):57-74. doi: 10.1515/hmbci-2014-0037.

引用本文的文献

1
The impact of altered gut microbiota and lipid metabolism on the progression of endometrial cancer in overweight populations.肠道微生物群和脂质代谢改变对超重人群子宫内膜癌进展的影响。
Front Endocrinol (Lausanne). 2025 Jul 31;16:1610534. doi: 10.3389/fendo.2025.1610534. eCollection 2025.
2
[Diagnostics and treatment of gout : S3 guideline of the German Society for Rheumatology and Clinical Immunology (DGRh, lead management) and participating professional societies: German Society for Internal Medicine (DGIM), German Society for General Medicine and Family Medicine (DEGAM), German Society for Nephrology (DGfN), German Society for Orthopaedic and Trauma Surgery (DGOU), German Society for Nutritional Medicine (DGEM), German Roentgen Society-Society for Medical Radiology (DRG), German Rheumatism League].痛风的诊断与治疗:德国风湿病与临床免疫学学会(DGRh,牵头管理)及参与的专业学会制定的S3指南:德国内科医学学会(DGIM)、德国全科医学与家庭医学学会(DEGAM)、德国肾脏病学会(DGfN)、德国骨科学与创伤外科学会(DGOU)、德国营养医学学会(DGEM)、德国放射学会 - 医学放射学学会(DRG)、德国风湿病联盟
Z Rheumatol. 2025 Jul 21. doi: 10.1007/s00393-025-01634-y.

本文引用的文献

1
Leptin secreted by adipocytes promotes EMT transition and endometrial cancer progression via the JAK2/STAT3 signalling pathway.脂肪细胞分泌的瘦素通过 JAK2/STAT3 信号通路促进 EMT 转化和子宫内膜癌的进展。
Adipocyte. 2024 Dec;13(1):2293273. doi: 10.1080/21623945.2023.2293273. Epub 2023 Dec 13.
2
Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges.肥胖相关性胰腺导管腺癌:治疗挑战
Semin Cancer Biol. 2023 Dec;97:12-20. doi: 10.1016/j.semcancer.2023.11.002. Epub 2023 Nov 4.
3
FABP4 in macrophages facilitates obesity-associated pancreatic cancer progression via the NLRP3/IL-1β axis.
3
Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort study.胰高血糖素样肽-1受体激动剂与减肥代谢手术及肥胖相关癌症风险的比较:一项观察性回顾性队列研究
EClinicalMedicine. 2025 May 11;83:103213. doi: 10.1016/j.eclinm.2025.103213. eCollection 2025 May.
4
Preoperative kidney tumor risk estimation with AI: From logistic regression to transformer.使用人工智能进行术前肾肿瘤风险评估:从逻辑斯谛回归到Transformer
PLoS One. 2025 May 30;20(5):e0323240. doi: 10.1371/journal.pone.0323240. eCollection 2025.
5
Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence.胰高血糖素样肽1受体激动剂与癌症风险:通过机制理解和临床证据推动精准医学发展
Biomark Res. 2025 Mar 27;13(1):50. doi: 10.1186/s40364-025-00765-3.
6
From Liking to Following: The Role of Food Preferences, Taste Perception, and Lifestyle Factors in Adherence to the Mediterranean Diet Among Young Individuals.从喜爱到遵循:食物偏好、味觉感知和生活方式因素在年轻人坚持地中海饮食中的作用
Nutrients. 2025 Feb 6;17(3):600. doi: 10.3390/nu17030600.
7
AdipoRon's Impact on Alzheimer's Disease-A Systematic Review and Meta-Analysis.脂联素受体激动剂对阿尔茨海默病的影响——一项系统评价与荟萃分析
Int J Mol Sci. 2025 Jan 8;26(2):484. doi: 10.3390/ijms26020484.
巨噬细胞中的脂肪酸结合蛋白4(FABP4)通过NLRP3/白细胞介素-1β轴促进肥胖相关的胰腺癌进展。
Cancer Lett. 2023 Oct 28;575:216403. doi: 10.1016/j.canlet.2023.216403. Epub 2023 Sep 21.
4
Exercise Test Predicts Both Noncardiovascular and Cardiovascular Death in a Primary Prevention Population.运动试验可预测一级预防人群中的非心血管和心血管死亡。
Mayo Clin Proc. 2023 Sep;98(9):1297-1309. doi: 10.1016/j.mayocp.2023.05.029.
5
Predicting the Future in Primary Care Patients Through Graded Exercise Testing.通过分级运动试验预测初级保健患者的未来。
Mayo Clin Proc. 2023 Sep;98(9):1270-1272. doi: 10.1016/j.mayocp.2023.07.019.
6
Pathophysiology of obesity and its associated diseases.肥胖及其相关疾病的病理生理学
Acta Pharm Sin B. 2023 Jun;13(6):2403-2424. doi: 10.1016/j.apsb.2023.01.012. Epub 2023 Jan 13.
7
Obesity and renal cell carcinoma: Biological mechanisms and perspectives.肥胖与肾细胞癌:生物学机制与展望。
Semin Cancer Biol. 2023 Sep;94:21-33. doi: 10.1016/j.semcancer.2023.06.001. Epub 2023 Jun 5.
8
Metabolic and bariatric surgery and obesity pharmacotherapy for cancer prevention: current status and future possibilities.代谢和减重手术与肥胖症药物治疗预防癌症:现状与未来可能。
J Natl Cancer Inst Monogr. 2023 May 4;2023(61):68-76. doi: 10.1093/jncimonographs/lgad003.
9
Tumor necrosis factor-α knockout mitigates intestinal inflammation and tumorigenesis in obese Apc mice.肿瘤坏死因子-α 基因敲除可减轻肥胖 Apc 小鼠的肠道炎症和肿瘤发生。
J Nutr Biochem. 2023 Jul;117:109355. doi: 10.1016/j.jnutbio.2023.109355. Epub 2023 Apr 20.
10
Systematic Review and Meta-Analysis of the Impact of Bariatric Surgery on Future Cancer Risk.系统评价和荟萃分析减重手术对未来癌症风险的影响。
Int J Mol Sci. 2023 Mar 24;24(7):6192. doi: 10.3390/ijms24076192.